Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Qinhuangdao
Clinical trial register · China

Clinical Trials in Qinhuangdao, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19282 matching records held by the registry are in this view. Synced 14 Nov 2026, 03:17 UTC
19282
Studies in scope
all four open statuses
11840
Recruiting now
open to new participants
2032
Lead sponsors
across recruiting studies
Top sites
Beijing 5606 Shanghai 3892 Guangzhou 3359 Hangzhou 1833 Wuhan 1342

Trials with a site in Qinhuangdao

15 of 19282 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
PCSK9 Inhibitor for Intracranial Atherosclerosis Related Acute Ischemic Stroke
NCT07466251Acute Ischemic Stroke AIS, Intracranial Atherosclerosis ICAS, Atherosclerotic Plaque
Peking Union Medical College Hospital
Phase 4
1,212
Beijing, Meizhou, Cangzhou, Qinhuangdao, Shijiazhuang, Tangshan, Harbin, Zhengzhou
2026-09-01
Active, closed
Boehringer Ingelheim
Phase 2
345
Huzhou, Jinan, Luoyang, Nanjing, Ningbo, Qinhuangdao, Tianjin, Yichang
2026-06-30
Recruiting
Personalized Neoantigen-pulsed Autologous Dendritic Cell Injections for Malignant Solid Tumors
NCT07752953Advanced Solid Tumor, Cancer, Malignant Solid Tumor
ZSky Biotech Inc
Not applicable
100
Qinhuangdao
2026-05-01
Recruiting
Capital Medical University
Phase 3
348
Huaibei, Suzhou, Heyuan, Maoming, Qinhuangdao, Tangshan, Anyang, Hebi
2026-04-22
Recruiting
NK Cell Therapy for Malignant Solid Brain Tumors
NCT07552233Malignant Solid Brain Tumors, Glioblastoma (GBM), Glioblastoma Multiforme (GBM), Brain Metastasis
Peking University Third Hospital
Not applicable
27
Beijing, Qinhuangdao, Zhengzhou
2026-04
Not yet open
Portal Vein Thrombosis in Cirrhosis: Incidence, Outcomes and Anticoagulation
NCT07422701Portal Vein Thrombosis, Liver Cirrhosis
Peking University First Hospital
Observational
2,522
Beijing, Shenzhen, Hengshui, Qinhuangdao, Wuxi, Qingdao
2026-02-01
Recruiting
Hepatopancreatobiliary Surgery Institute of Gansu Province
Not applicable
120
Lanzhou, Qinhuangdao, Shenyang, Yinchuan, Xi’an
2026-01-07
Not yet open
Left Ventricular Myocardial Work for Predicting Response to CRT
NCT07319065CRT Non-Response, LBBB, HF - Heart Failure, Healthy Adult
First Hospital of China Medical University
Observational
3,240
Hefei, Wannan, Fuzhou, Guizhou, Xiamen, Lanzhou, Jiangmen, Qinhuangdao
2026-01-01
Active, closed
Capital Medical University
Phase 3
692
Suzhou, Zhangzhou, Qinzhou, Langfang, Qinhuangdao, Tangshan, Harbin, Anyang
2025-12-05
Recruiting
PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis
NCT06902740Intracranial Atherosclerosis, Intracranial Artery Stenosis, Atherosclerotic Plaque
Peking Union Medical College Hospital
Phase 4
300
Beijing, Meizhou, Cangzhou, Qinhuangdao, Shijiazhuang, Tangshan, Harbin, Zhengzhou
2025-11-07
Active, closed
Amgen
Phase 3
12,800
Bengbu, Beijing, Guangzhou, Huizhou, Yulin, Qinhuangdao, Shijiazhuang, Harbin
2025-07-25
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
Amgen
Phase 3
5,056
Hefei, Beijing, Guangzhou, Haikou, Qinhuangdao, Shijiazhuang, Daqing, Harbin
2025-06-25
Recruiting
Qinhuangdao Hospital of Traditional Chinese Medicine
Phase 4
200
Beijing, Qinhuangdao, Kaifeng, Jinan, Weifang, Kunming
2024-11-04
Recruiting
Beijing Tiantan Hospital
Observational
2,000
Beijing, Baoding, Cangzhou, Chengde, Handan, Langfang, Qinhuangdao, Shijiazhuang
2024-08-01
Recruiting
China-Japan Friendship Hospital
Phase 4
336
Beijing, Baoding, Qinhuangdao, Gongyi, Yangzhou, Jining, Qingdao, Changzhi
2023-03-29
Rows per page Showing 1–15 of 15
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 14 November 2026. https://priyalifescience.com/clinical-trials-china/city/qinhuangdao

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,282 studies in total at the last sync on 14 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 15 of those studies with a site in Qinhuangdao.

How many clinical trials are recruiting in Qinhuangdao?

9 of the 15 studies on this page are recruiting new participants as of the 14 Nov 2026, 03:17 UTC sync. A further 3 have not yet opened recruitment, 3 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Qinhuangdao), 15 studies
PhaseStudiesRecruitingShare
Phase 34226.7%
Phase 44326.7%
Not applicable3320%
Observational3120%
Phase 2106.7%

Most active sponsors

Lead sponsors with the most studies (Qinhuangdao)
Lead sponsorStudiesRecruiting
Amgen21
Capital Medical University21
Peking Union Medical College Hospital21
Beijing Tiantan Hospital11
Boehringer Ingelheim10
China-Japan Friendship Hospital11
First Hospital of China Medical University10
Hepatopancreatobiliary Surgery Institute of Gansu Province11
Peking University First Hospital10
Peking University Third Hospital11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.